A Pivotal Study of Sensory Stimulation in Alzheimer's Disease
This study is for people with mild to moderate Alzheimer's disease (AD). It's a special kind of study called "randomized" and "double-blind," which means participants won't know if they're getting real treatment or a pretend one (sham). The treatment involves using a Sensory Stimulation System that gives sights and sounds to help slow down the disease. Over 12 months, 530 participants will use this system daily. The study checks if this sensory treatment helps with daily activities and thinking skills using special tests like the Alzheimer's Disease Cooperative Study-Activities of Daily Living (ADCS-ADL) and Mini-Mental State Exam (MMSE).
Key Points:
- Study lasts for 12 months with regular check-ins, including some by phone.
- Participants may need to do more tests, like a lumbar puncture, for extra research.
- Eligibility includes people aged 50-90 with mild to moderate AD, among other criteria.
How understandable was the trial content above?
Hard to understand
Easy to understand